Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Journées Internationales de Biologie 2006

By Labmedica staff writers
Posted on 22 Dec 2006
The annual Journées Internationales de Biologie (JIB) was held November 7-10, 2006, in Paris (France) under the auspices of the French Ministère de la Santé et des Solidarités and the Caisse Nationale d'Assurance Maladie (CNAM). More...


This annual clinical biology meeting in Europe combined an expanding trade show with 165 confirmed exhibitors and a high-level scientific program that focused on state-of-the-art and current practices in the medical laboratory. Aimed at biologists in both the private and hospital sectors, biomedical engineers, technicians, and hospital physicians, JIB provided extensive and comprehensive information on progress and technical advances in clinical biology.

Tunisia was the invited guest country at the JIB 2006, succeeding Belgium, Spain, Portugal, and Italy. The opening ceremony of the exhibition was held at the Tunisian pavilion, the "Médina Ibn Khaldoun” in the presence of Dr. Mohamed Ridha Kechrid, minister of health of Tunisia, Tijani Haddad, minister of tourism of Tunisia, and Mohamed Raouf Najar, ambassador of Tunisia in Paris. During the opening address, Dr. Mohamed Ridha Kechrid underlined the strong links that have been established between France and Tunisia's biologists, giving as an example the successful collaboration of the "Bio Quality Tunisia.”

The "Scientific Day of Tunisia” retraced the history of medicine and biology in Tunisia and highlighted the medical specificities of the country. It also focused on the quality system at the National Blood Transfusion Center in Tunisia, and gave insight into gastric pathologies and Helicobacter pylori infections, as well as hemoglobinopathies in Tunisia.

This year, the scientific panel, traditionally composed of the Journées Biologiques de Lariboisière, the Société Française de Biologie Clinique (SFBC), and L'institut Nationale de la Santé et de la Recherche Médicale (INSERM), also consisted of the Journées de Internat des Hôpitaux de Paris (JIPPIF), the Société Française Vitamines et Biofacteurs (SFVB), and the Société Francophone d'Etude et de Recherche sur les Eléments Toxiques et Essentiels (SFERETE).

The scientific program, which consisted of 12 sessions, about 100 speakers, and 130 poster sessions, was attended by over 1,600 delegates. It offered a unique opportunity to become acquainted with state-of-the-art information about rare diseases. New subjects that are likely to influence future practices in biologic investigations, such as molecular imaging and apoptosis as well as more classical aspects of biology, were discussed.



Related Links:
Journées Internationales de Biologie

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.